Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely domperidone (as domperidone maleate) 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely domperidone (as domperidone maleate) 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Metoclopramide hydrochloride 5 mg and paracetamol 500 mg effervescent powder for oral suspension sachet |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Metoclopramide hydrochloride 5 mg and paracetamol 500 mg effervescent powder for oral suspension sachet |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Caffeine 25 mg and paracetamol 450 mg oral tablet |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Paracetamol 150 mg and sodium salicylate 100 mg oral tablet |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Paracetamol 150 mg and sodium salicylate 100 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely butalbital 50 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely butalbital 50 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg and paracetamol 325 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg and paracetamol 325 mg oral capsule |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely butalbital 50 milligram and paracetamol 650 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely butalbital 50 milligram and paracetamol 650 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely butalbital 50 milligram and paracetamol 650 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Acetaminophen+codeine phosphate 300mg/30mg tablet |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely codeine phosphate 60 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Acetaminophen + dichloralantipyrine + isometheptene 325mg/100mg/65mg capsule |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Acetaminophen + dichloralantipyrine + isometheptene 325mg/100mg/65mg capsule |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Hydrocodone bitartrate 10 mg and paracetamol 325 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hydrocodone bitartrate 10 mg and paracetamol 325 mg oral tablet |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hydrocodone bitartrate 5 mg and paracetamol 500 mg oral capsule |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Acetaminophen+butalbital+caffeine 325mg/50mg/40mg capsule |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Acetaminophen+butalbital+caffeine 325mg/50mg/40mg capsule |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hydrocodone bitartrate 7.5 mg and paracetamol 650 mg oral tablet |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Paracetamol 500 mg and phenyltoloxamine citrate 60 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Paracetamol 500 mg and phenyltoloxamine citrate 60 mg oral tablet |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely paracetamol 325 milligram and tramadol 37.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Acetaminophen+butalbital+caffeine 500mg/50mg/40mg tablet |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Acetaminophen+butalbital+caffeine 500mg/50mg/40mg tablet |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Butalbital 50 mg and paracetamol 325 mg oral tablet |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrocodone bitartrate 2.5 mg and paracetamol 500 mg oral tablet |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely oxycodone hydrochloride 7.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely oxycodone hydrochloride 7.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Oxycodone hydrochloride 7.5 mg and paracetamol 500 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Oxycodone hydrochloride 7.5 mg and paracetamol 500 mg oral tablet |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Oxycodone hydrochloride 10 mg and paracetamol 650 mg oral tablet |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely aspirin 250 milligram and caffeine 65 milligram and paracetamol 250 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Oxycodone hydrochloride 7.5 mg and paracetamol 300 mg oral tablet |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Oxycodone hydrochloride 7.5 mg and paracetamol 300 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely oxycodone hydrochloride 2.5 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely oxycodone hydrochloride 2.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 400 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hydrocodone bitartrate 2.5 mg and paracetamol 325 mg oral tablet |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Caffeine 15 mg and codeine phosphate 15 mg and paracetamol 300 mg oral tablet |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Caffeine 15 mg and codeine phosphate 15 mg and paracetamol 300 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 30 mg oral tablet |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 30 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ibuprofen and paracetamol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ibuprofen- and paracetamol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely ibuprofen 20 milligram/1 milliliter and paracetamol 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely ibuprofen 20 milligram/1 milliliter and paracetamol 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only ibuprofen and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing ibuprofen and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely paracetamol 1 gram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paracetamol 1 gram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lornoxicam- and paracetamol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lornoxicam and paracetamol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lornoxicam 4 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lornoxicam 4 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing lornoxicam and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lornoxicam and paracetamol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paracetamol 1 gram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paracetamol 1 gram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol 50 mg/mL oral solution |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol 50 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol 100 mg rectal suppository |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol 100 mg rectal suppository |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol 100 mg oral tablet |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol 100 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol 300 mg oral tablet |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol 300 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol 25 mg/mL oral suspension |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol 25 mg/mL oral suspension |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aceclofenac 100 mg and chlorzoxazone 250 mg and paracetamol 325 mg oral tablet |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aceclofenac 100 mg and chlorzoxazone 250 mg and paracetamol 325 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aceclofenac- and chlorzoxazone- and paracetamol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing aceclofenac and chlorzoxazone and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aceclofenac and chlorzoxazone and paracetamol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only aceclofenac and chlorzoxazone and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paracetamol 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paracetamol 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing mefenamic acid and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |